MedTrace Logo

Treatment of Depression With Mindfulness, Acceptance and Commitment

NCT03692130 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-08-20

No results posted yet for this study

Summary

Randomized trial to proof the effects and efficacy of a new mindfulness and acceptance based group-treatment for depressive patients

Conditions

Interventions

BEHAVIORAL

Mindfulness, Acceptance and Commitment-Therapy

Psychotherapeutic intervention to treat depressive patients with special exercises and education to be mindful, to accept situations and behaviors and to commit with the situation or the possibility to change.

BEHAVIORAL

Jacobson

Relaxation treatment in technique of Jacobson

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • Neuropsychiatrischen Zentrums Hamburg-Altona

    lead OTHER

Principal Investigators

  • Peter Tonn, MD · Managing Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-18
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03692130 on ClinicalTrials.gov